Genmab strikes deal with German biotech company
![Photo: Genmab, PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article5824812.ece/ALTERNATES/schema-16_9/Genmab_silver_on_green_sideview.jpg)
The Danish-based biotech group Genmab has signed a commercial agreement concerning its DuoBody technology with Germany’s Biontech in the immuno-oncology field, Genmab writes in an announcement.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Genmab CEO sees bright future
For subscribers
This is how Genmab finds M&A targets
For subscribers
Increased belief in Genmab’s potential blockbuster
For subscribers